>
Organicell Regenerative Medicine Inc logo

BPSR - Organicell Regenerative Medicine Inc Share Price

$0.3 -0.0  -3.3%

Last Trade - 2:46pm

Sector
Consumer Defensives
Size
Small Cap
Market Cap £228.3m
Enterprise Value £228.5m
Revenue £2.64m
Position in Universe 4055th / 6853
Bullish
Bearish
Unlock BPSR Revenue
Momentum
Relative Strength (%)
1m +419.8%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -50.8%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Oct 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
0.15 0.18 0.57 0.96 1.70 3.06 +83.3%
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the three months ended 31 January 2021,Organicell Regenerative Medicine Inc revenues increased 96%to $1.4M. Net loss increased from $696K to $8.2M. Revenuesreflect an increase in demand for the Company's productsand services due to favorable market conditions. Higher netloss reflects General and administrative expenses increasefrom $1.3M to $9.4M (expense). Basic Earnings per Shareexcluding Extraordinary Items totaled to -$0.01.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

BPSR Revenue Unlock BPSR Revenue

Net Income

BPSR Net Income Unlock BPSR Revenue

Normalised EPS

BPSR Normalised EPS Unlock BPSR Revenue

PE Ratio Range

BPSR PE Ratio Range Unlock BPSR Revenue

Dividend Yield Range

BPSR Dividend Yield Range Unlock BPSR Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
BPSR EPS Forecasts Unlock BPSR Revenue
Profile Summary

Organicell Regenerative Medicine, Inc., formerly Biotech Products Services and Research, Inc., is engaged in the healthcare industry, principally focused on supplying products and services related to the field of regenerative anti-aging medicine (RAAM). The Company focuses on the referral of cellular therapies for treating neurodegenerative, inflammatory and autoimmune conditions for patients across the world. The Company intends to distribute the RAAM Products and market RAAM-related services through a referral network of doctors and clinics. It also intends to develop a network of branded destination domestic and international clinics capable of providing RAAM-based therapies and treatments. Its RAAM-related operations are conducted through its subsidiaries, Beyond Cells Corp., engaged in providing anti-aging and cellular therapy patient referral and product sales, and General Surgical of Florida, Inc., engaged in sale of cellular therapy products to doctors and hospitals.

Directors
Last Annual October 31st, 2020
Last Interim January 31st, 2021
Incorporated August 9, 2011
Public Since November 8, 2013
No. of Shareholders: 200
No. of Employees: 18
Sector Consumer Defensives
Industry Food & Drug Retailing
Index
Exchange Pink Sheets on Nasdaq
Shares in Issue 1,041,341,874
Free Float (0.0%)
Eligible for
× ISAs
SIPPs
BPSR Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for BPSR
Upcoming Events for BPSR
Frequently Asked Questions for Organicell Regenerative Medicine Inc
What is the Organicell Regenerative Medicine Inc share price?

As of 2:46pm, shares in Organicell Regenerative Medicine Inc are trading at $0.3, giving the company a market capitalisation of £228.3m. This share price information is delayed by 15 minutes.

How has the Organicell Regenerative Medicine Inc share price performed this year?

Shares in Organicell Regenerative Medicine Inc are currently trading at $0.3 and the price has moved by 0.675k% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Organicell Regenerative Medicine Inc price has moved by 0.424k% over the past year.

What are the analyst and broker recommendations for Organicell Regenerative Medicine Inc?

There are no analysts currently covering Organicell Regenerative Medicine Inc.

When will Organicell Regenerative Medicine Inc next release its financial results?

Organicell Regenerative Medicine Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2022-01-31
What is the Organicell Regenerative Medicine Inc dividend yield?

Organicell Regenerative Medicine Inc does not currently pay a dividend.

Does Organicell Regenerative Medicine Inc pay a dividend?

Organicell Regenerative Medicine Inc does not currently pay a dividend.

When does Organicell Regenerative Medicine Inc next pay dividends?

Organicell Regenerative Medicine Inc does not currently pay a dividend.

How do I buy Organicell Regenerative Medicine Inc shares?

To buy shares in Organicell Regenerative Medicine Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Organicell Regenerative Medicine Inc?

Shares in Organicell Regenerative Medicine Inc are currently trading at $0.3, giving the company a market capitalisation of £228.3m.

Where are Organicell Regenerative Medicine Inc shares listed? Where are Organicell Regenerative Medicine Inc shares listed?

Here are the trading details for Organicell Regenerative Medicine Inc:

Country of listing: United States
Exchange: PNK
Ticker Symbol: BPSR
What kind of share is Organicell Regenerative Medicine Inc?

Based on an overall assessment of its quality, value and momentum, Organicell Regenerative Medicine Inc is currently classified as a Style Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Organicell Regenerative Medicine Inc share price forecast 2021?

We were not able to load any forecast data for Organicell Regenerative Medicine Inc.

How can I tell whether the Organicell Regenerative Medicine Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Organicell Regenerative Medicine Inc. Over the past six months, the relative strength of its shares against the market has been 0.122k%. At the current price of $0.3, shares in Organicell Regenerative Medicine Inc are trading at 0.102k% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Organicell Regenerative Medicine Inc PE Ratio?

We were not able to find PE ratio data for Organicell Regenerative Medicine Inc.

Who are the key directors of Organicell Regenerative Medicine Inc?

Organicell Regenerative Medicine Inc's management team is headed by:

Albert Mitrani - PRE
Ian Bothwell - CFO
Maria Mitrani - CSO
George Shapiro - OTH
Michael Carbonara - IND
Allen James Meglin - IND
Who are the major shareholders of Organicell Regenerative Medicine Inc?

Here are the top five shareholders of Organicell Regenerative Medicine Inc based on the size of their shareholding:

Mitrani (Albert) Individual Investor
Percentage owned: 15.72% (163.8m shares)
Bothwell (Ian T) Individual Investor
Percentage owned: 13.19% (137.4m shares)
Management and Business Associates, L.L.C. Corporation
Percentage owned: 12.33% (128.4m shares)
Mitrani (Maria Ines) Individual Investor
Percentage owned: 10.9% (113.6m shares)
Shapiro (George Craig M.D.) Individual Investor
Percentage owned: 7.75% (80.7m shares)
Similar to BPSR
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.